Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Parent-Adolescent Interactions and Adolescent Development (PAIT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by George Mason University
Sponsor:
Collaborators:
ABMRF/The Foundation for Alcohol Research
Information provided by (Responsible Party):
Tara M. Chaplin, Ph.D., George Mason University
ClinicalTrials.gov Identifier:
NCT01572441
First received: April 3, 2012
Last updated: January 7, 2014
Last verified: January 2014
  Purpose

The purpose of this study is to observe parent-adolescent interactions and to examine the parenting behaviors and adolescent emotional and physiological responses that are associated with youth's substance use.


Condition
Substance Abuse

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Responses During Parent-child Interactions and Alcohol Use Behavior in Adolescents.

Resource links provided by NLM:


Further study details as provided by George Mason University:

Primary Outcome Measures:
  • Substance Use [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 6 month follow-up ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 1 year follow-up ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 2 year follow-up ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 3 year follow-up ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.


Biospecimen Retention:   Samples With DNA

Retain saliva sample.


Estimated Enrollment: 400
Study Start Date: September 2009
Estimated Study Completion Date: July 2017
Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
10-17 year olds
No intervention administered. This is a longitudinal observational study including observation of behaviors and physiological responses.

  Eligibility

Ages Eligible for Study:   10 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

10-17 year olds and their primary caregivers.

Criteria

Inclusion Criteria:

  • Adolescent between ages 10-17 years

Exclusion Criteria:

  • For adolescent, Intelligence Quotient (IQ) < 70 on standardized test, for parent, evidence of inability to read or write.
  • Evidence of a psychotic disorder for parent or adolescent
  • Diagnosis of autism or pervasive developmental disorder for adolescent, as determined by parent report in the screening.
  • For adolescent, current need for acute treatment of a psychiatric disorder, as determined by parent report in the study screening.
  • For adolescent and parent, inadequate English proficiency to comprehend task instructions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01572441

Locations
United States, Connecticut
Yale Stress Center Recruiting
New Haven, Connecticut, United States, 06519
Contact: Tara Chaplin, Ph.D.    203-737-5201    tara.chaplin@yale.edu   
Principal Investigator: Tara Chaplin, Ph.D.         
Sponsors and Collaborators
George Mason University
ABMRF/The Foundation for Alcohol Research
Investigators
Principal Investigator: Tara Chaplin, Ph.D. Yale University
  More Information

Publications:
Responsible Party: Tara M. Chaplin, Ph.D., Assistant Professor of Psychology, George Mason University
ClinicalTrials.gov Identifier: NCT01572441     History of Changes
Other Study ID Numbers: 0909005677, K01DA024759, R10629
Study First Received: April 3, 2012
Last Updated: January 7, 2014
Health Authority: United States: Institutional Review Board
United States: Federal Government

ClinicalTrials.gov processed this record on November 20, 2014